What Do Blood Tests Reveal About Metabolic Health? Key Markers and Early Warning Signs
Fasting insulin, HbA1c, C-peptide, triglyceride-to-HDL ratio, and liver enzymes (ALT, AST) — these markers detect metabolic dysfunction years before symptoms appear. Fewer than 1 in 3 American adults meet all criteria for optimal metabolic health. Standard metabolic panels include glucose and basic liver enzymes but typically omit fasting insulin, C-peptide, and advanced lipid ratios — the markers most sensitive to early insulin resistance.
Which Biomarkers Detect Metabolic Problems Earliest?
C-peptide is a byproduct of insulin production and serves as a stable marker of insulin secretion. Elevated C-peptide indicates the pancreas is working harder to maintain normal glucose — a sign of developing insulin resistance.
HbA1c reflects average blood glucose over approximately 3 months. Pre-diabetes begins at HbA1c of 5.7% — detectable before fasting glucose becomes abnormal. Annual HbA1c testing delays detection of metabolic shifts by up to 9 months.
Fasting glucose is a late-stage marker — often normal until insulin resistance is well advanced. By the time fasting glucose rises above 100 mg/dL, compensatory insulin production has likely been elevated for years.
Liver enzymes ALT and AST can indicate non-alcoholic fatty liver disease (NAFLD), which affects approximately 25% of adults globally and is strongly associated with metabolic syndrome.
Triglyceride-to-HDL ratio above 2.0 serves as an accessible proxy for insulin resistance and is calculable from any standard lipid panel.
SiPhox Heart & Metabolic panel includes C-peptide, HbA1c, ALT, AST, triglycerides, HDL, and eGFR. For the full biomarker list, see our page on SiPhox biomarker panels.
What Is the Triglyceride-to-HDL Ratio and Why Does It Matter?
Triglyceride-to-HDL ratio is a simple, widely available, and underutilized marker of metabolic health.
Triglyceride-to-HDL ratio above 2.0 correlates with insulin resistance, small dense LDL particles, and elevated cardiovascular risk.
Triglyceride-to-HDL ratio below 1.5 is associated with favorable metabolic health and larger, less atherogenic LDL particles.
Triglyceride-to-HDL ratio is calculable from any lipid panel that includes triglycerides and HDL — no additional testing required. It responds to dietary changes within 4-8 weeks, making it useful for tracking intervention effectiveness.
Limitations and Considerations
- Metabolic health is multifactorial. Biomarkers alone do not diagnose metabolic syndrome or insulin resistance. Body composition, physical activity, diet, sleep, and stress all contribute to metabolic status.
- Abnormal results require physician evaluation. Elevated liver enzymes, HbA1c above 5.7%, or other abnormal metabolic markers should be discussed with a healthcare provider for proper clinical interpretation.
- Conflict of interest disclosure. This page is published by SiPhox Health, which sells testing panels that measure metabolic biomarkers. The clinical significance of these markers is supported by independent metabolic research.
Written by Tsolmon Tsogbayar, MD. Reviewed by Pavel Korecky, MD.
SiPhox Health is a wellness-only service and is not designed to diagnose, prevent, or treat any disease.